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Several studies demonstrate that cigarette smoking is detri-
mental to bonehealth and impairs bonehealing. Gerdhem and
Obrant1 showed in elderly women that smoking significantly
reduced hip and total body bone mineral density. Andersen
et al2 reported that smoking resulted in an odds ratio of
nonunion of 2.01 in lumbar fusion patients. Ueng et al3
demonstrated that intermittent exposure to cigarette smoke
in rabbits reduced torsional strength of the tibia during tibial
lengthening procedures. Laroche et al4 found that smoking
significantly reduced serum osteocalcin levels in males, and
NersessianandArutyunyan5 showed that exposure to cigarette
smoke increased osteoclastogenic activity in mice.
Nicotine has been implicated as the agent in cigarette
smoke that is responsible for the ill effects of smoking on bone
health. Hollinger et al6 reported that nicotine adversely
affected bone healing in a rat model, and Wing et al7 showed
that chronic exposure to nicotine decreased fusion rates in a
rabbit model and that quitting improved fusion rates. Silcox
et al8 found that systemic nicotine had a negative effect on
bone fusion in a rabbit model of posterior lumbar fusion.
Furthermore, Riebel et al9 showed that nicotine increased
nonunion in a bone graft model in rabbits and correlated it to
reduced vascularization in the bone graft. They did, however,
notice a varied response to nicotine among different animals,
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Abstract Previous studies by our group showed that nicotine delivered via a transdermal nicotine
patch significantly enhanced posterior spinal fusion rates in rabbits. Nicotine transder-
mal patches provide a steady serum level; there may be a dose-dependent effect of
nicotine on posterior spinal fusion. In an in vitro cell culture model of rabbit bone
marrow–derived osteoblast-like cells, cells were exposed to different concentrations of
nicotine (0, 20, 40, 80 ng/mL and 10, 100, 250 μg/mL). Wells were stained with an
alkaline phosphatase (ALP) staining kit to determine ALP enzyme activity. Cells were
stained with Von Kossa for mineralization. A two-way analysis of variance (ANOVA) using
dose and time as variables showed significant differences among groups; post hoc
analysis showed that the 100-μg/mL dose of nicotine significantly enhanced ALP activity
over controls. A one-way ANOVA using dose as the variable showed that the 100- and
250-μg/mL doses had significantly greater mineralization than controls. Dose-response
analysis revealed a statistically significant effect of nicotine dose on ALP activity and Von
Kossa activity. The effects of nicotine on spinal fusion may be dose-dependent and due
to stimulation of osteoblastic activity. Nicotine may not be responsible for the inhibited
bone healing observed in smokers.
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which they attributed to “predisposition” of the individual
animals.
The mechanism by which nicotine affects bone health and
healing is not clearly known. Theiss et al10 showed that gene
expression of type I and II collagen, bone morphogenic
protein (BMP)-2, BMP-4, BMP-6, basic fibroblast growth
factor, and vascular endothelial growth factor were reduced
by systemic administration of nicotine. Nicotine reduced
vascularization to autologous cancellous bone grafts in the
anterior chamber of the eye in a rabbit model.11 Feitelson
et al12 reported that nicotine increased the effect of norepi-
nephrine in constricting bone vasculature. To the contrary,
however, Heeschen et al13 found nicotine to be a potent
stimulator of angiogenesis in three different animal models
not involving bone, and Clouse et al14 found that results
of coronary artery bypass grafts in a canine model were
unaffected by nicotine.
In a previous animal study designed to evaluate the effects
of direct current electrical stimulation on spinal fusion in
rabbits exposed to nicotine, we found that both the nicotine
control group of animals (fusion þ nicotine administration)
and the direct current stimulation group (fusion þ nicotine þ
direct current stimulator) had increased fusion rates compared
with the negative control group (fusion alone).15 In light of the
above information, we found this intriguing, as this was
contrary to what other groups had found.6–9 To resolve this
issue, the current study was undertaken to see if the effects
of nicotine on bone could be dose-dependent and if this
could be demonstrated in an in vitro evaluation of osteoblast
activity.
Materials and Methods
Establishing a Bone Marrow–Derived Osteoblast-Like
Cell Culture System
Bone marrow was isolated from adult male New Zealand
white rabbit femurs via aspiration with an 18-gauge needle.
The cells in the bone marrow were expanded in monolayer
culture and split and subcultured according to standard
protocols developed for rat models.16,17 Approximately
5  104 cells were placed in each treatment well of a
24-well plate and exposed to one of three treatments: (1)
minimum essential medium (MEM); (2) 40 ng/mL dexameth-
asone and MEM; or (3) 50 ng/mL BMP-2, 40 ng/mL dexa-
methasone, andMEM. The noncontrol treatments were given
additional mineralizing agents of 2.8  104 mol/L concen-
tration of L-ascorbic acid and 10 mmol/L concentration of
β-glycerophosphate starting on day 7 and every media
change thereafter.18,19 The media was changed every
3 days. Wells were stained with an alkaline phosphatase
staining kit (Sigma, St. Louis, MO) to determine the activity
of the alkaline phosphatase enzyme, an early indicator of
osteogenesis,20 and Von Kossa,21which indicates mineraliza-
tion, a late stage of osteogenesis. The amount of staining was
quantified as follows: Digital images of the stained wells
were obtained at low power such that the entire well
could be accommodated in one picture frame (as can be
seen in ►Figs. 1–4). The images were imported into image
analysis software (Image J: http://rsbweb.nih.gov/ij/). Using a
customwritten macro, it was possible to measure the area of
the image that was stained. The measured area depended on
the threshold value used for the image (portions of the image
with staining intensity below the threshold would be
ignored; thus the higher the threshold value, the lower the
stained area). The appropriate threshold value was deter-
mined from the control samples; in the control samples, the
threshold valuewas adjusted until the stained area became 0.
Effects of Nicotine on Bone Marrow–Derived
Osteoblast-Like Cells
The cell culture conditions were optimized based on previous
experiencewith these cells. Approximately 3  103 cellswere
placed in each treatment well of a 24-well plate and culture
medium containing MEM and 40 ng/mL dexamethasone was
added. All treatments were given 2.8  104 mol/L concen-
tration of L-ascorbic acid and 10 mmol/L concentration of
β-glycerophosphate after day 7 and with every media change
after that. Media were changed every 3 days. This regimen
was shown to induce osteogenesis in the cells. Cells
were exposed to one of six concentrations of nicotine: 20,
Figure 1 (A) Rabbit bone marrow–derived cells were cultured in monolayer under different conditions and tested for alkaline phosphatase
activity (proportional to red color) at different times. (B) Alkaline phosphatase enzyme activity increased through day 21 and declined by day 28.
Analysis of variance showed that some groups were significantly different from others (f ¼ 0.0021 at p ¼ 0.05 level) in terms of alkaline
phosphatase activity. MEM, minimum essential medium; Dexa, dexamethasone; BMP, bone morphogenic protein.
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40, 80 ng/mL and 10, 100, 250 μg/mL. Control cells were not
exposed to nicotine. Wells were stained with an alkaline
phosphatase staining kit (Sigma) to determine the activity
of the alkaline phosphatase enzyme. Cells were also stained
with Von Kossa to determine mineralization.
Results
Establishing a Bone Marrow–Derived Osteoblast-Like
Cell Culture System
The trend in the data showed that alkaline phosphatase
activity increased over a 3-week period with a decline in
activity seen at week 4 (►Figs. 1A, 1B). Von Kossa staining
was not observed at sampling times of weeks 1 through 3.
Week 4 showed a positive stain for Von Kossa (►Figs. 2A, 2B)
with theMEM þ BMP-2 þ dexamethasone treatment having
the largest percent of area coverage (p ¼ 0.001). This mim-
icked the behavior of other preosteoblastic cells that have
been induced to undergo osteogenesis.17,22
Effects of Nicotine on Bone Marrow–Derived
Osteoblast-Like Cells
Control cells behaved as expected, with increasing alkaline
phosphatase activity up to 3 weeks and dropping off slightly
at 4 weeks. As expected, there was no appreciable Von Kossa
staining up to 3 weeks but after 4 weeks, the control cells
stained positively for Von Kossa. A two-way analysis of
variance (ANOVA) using dose and time as variables showed
significant differences among groups (f ¼ 0.0021). A post hoc
analysis (least squares means differences Student t test)
among groups showed that the 100-μg/mL dose of nicotine
significantly enhanced alkaline phosphatase activity over
controls (►Fig. 3). Von Kossa staining was not observed at
sampling times of weeks 1 through 3. Week 4 showed a
positive stain for Von Kossa (►Fig. 4). A one-way ANOVA
using dose as the variable was performed, and the 100- and
250-μg/mL dose had significantly greater mineralization than
controls.
The dose-response analysis revealed a statistically signifi-
cant (p ¼ 0.001) effect of nicotine dose on alkaline phospha-
tase activity and Von Kossa activity at 4weeks (►Figs. 5A, 5B).
The alkaline phosphatase activity at 1, 2, and 3weeks showed
the same trends but the results were not statistically
significant.
Discussion
Our study demonstrated a statistically significant effect of
nicotine dose on osteoblast activity in vitro. Bone marrow–
derived osteoblastic cells increase alkaline phosphatase ac-
tivity in the presence of nicotine, although statistically signif-
icant effects were only seen for high doses in the μg/mL range.
The maximum effect was observed at the 100-μg/mL dosage.
Mineralization was enhanced when nicotine was adminis-
tered with higher dosages, resulting in more mineralization
(100- and 250-μg/mL dosages). In a similar study, nicotine has
been shown to have a significant dose-dependent effect on
the activity of osteoblastic cell lines with increased alkaline
phosphatase activity and deposition of calcium.23 Fang et al24
showed that nicotine suppressed proliferation and increased
alkaline phosphatase activity in UMR 601 osteoblast-like
cells. Walker et al.25 showed that nicotine had a direct effect
Figure 2 (A) Rabbit bone marrow–derived cells were cultured in monolayer and tested for calcium deposition by Von Kossa staining (black) at
different time points. In the negative controls, a chelator of calcium was added before Von Kossa staining. The clear wells of the negative
control indicated that the stain seen was due to deposited calcium and was not an artifact. (B) Von Kossa staining was not observed through
day 21 but appeared at day 28. Treatment groups showed significantly higher mineralization than controls on day 28 (p ¼ 0.001). MEM, minimum
essential medium; Dexa, dexamethasone; BMP, bone morphogenic protein.
Figure 3 Rabbit bone marrow–derived cells were cultured in
monolayer under different conditions and tested for alkaline
phosphatase activity at different time points. Alkaline phosphatase
enzyme activity was significantly enhanced by nicotine at 100-μg/mL
dose over the control at p < 0.05.
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on osteoblasts that includes increased expression of osteo-
pontin. In that study, cells expressed the nicotine receptor α
4 unit and the effects of nicotine were blocked by receptor
antagonists. Rothem et al reported a dose-dependent effect of
nicotine on bone metabolism in osteoblastic cells, although
low-dose nicotine (equivalent to a light smoker) up-regulated
expression of osteocalcin, type I collagen, and alkaline phos-
phatase, and a high concentration inhibited expression of
these genes.26 Kim et al27 showed a bimodal effect of nicotine
on the proliferation and osteoblastic differentiation of mes-
enchymal stem cells derived from alveolar bone marrow.
These studies support the fact that nicotine can have a
positive role in mesenchymal stem cells and osteoblast
function and may act in a dose-dependent manner. Thus,
the increased fusion rates we previously observed in rabbits
exposed to nicotine in vivo might be explained partially by
enhanced osteoblastic activity due to nicotine.
The dose of nicotine exposure in the current study, how-
ever, is substantially higher than that administered during
our prior in vivo study.15 This disparity in doses that causes
responses in the in vivo and in vitro systems continues to be a
concern and demands further investigation. One potential
explanation could be that the bone marrow aspirate we used
contains many cell types, only a small number of which are
osteoblast progenitors, and thus a higher dose is required to
elicit a statistically significant difference. The sensitivity of
the assay could also be a factor. However, the trend is
consistent with dosage, although very high doses were
required for statistical significance. The fact that our in vivo
and in vitro data trend in the same direction despite dose
differences is encouraging.
Gullihorn et al,36 working with an osteoblastic cell line,
showed statistically significant responses of nicotine for as
low as 12.5 ng/mL, which is well within the circulating levels
of nicotine in smokers. Kim et al27 showed bimodal responses
that changed as the concentration of nicotine shifted between
the 1 to 2 mmol/L range. Thus the specific cell-culture model
seems to heavily influence the dosages at which the effects of
nicotine are seen.
Interestingly, in many models of posterior spinal fusion, in
vivo administration of nicotine has been shown to decrease
fusion rates. Decreased angiogenesis measured by decreased
vascular ingrowth into autogenous cancellous bone grafts9
and inhibition of the expression of cytokines associated with
neovascularization10 have been observed in these models.
However, in other settings, such as in tumor or ischemia
models, nicotine is a potent enhancer of angiogenesis.13 The
overall relationship between bony fusion rates and nicotine
may depend on many factors including both angiogenesis
and osteoblastic activity. Nicotine seems to positively affect
osteoblasts and negatively affect vascularization in bone and
increase angiogenesis in other models.
The effects of nicotine alone on bone health are not
conclusive. High doses of nicotine administered via mini–
osmotic pumps (1.5 to 4 times as much as heavy smokers)
administered for 12 weeks caused no difference in bone mass
and strength in female rats,28 although bone mineral density
was lowered in male rats given nicotine via drinking water in
a different study.29 In growing female rats, nicotine had no
effect on bone mineral content, bone strength, or markers
of bone metabolism such as vitamin D, calcitonin, and para-
thyroid hormone.30 In adult female rats, a limited effect was
noticed for high concentrations of nicotine.31 Gotfredsen et al
Figure 5 A dose-response analysis showed a statistically significant
effect of dose on osteoblastic activity markers (A) alkaline phosphatase
(ALPase) activity (p ¼ 0.0139) and (B) Von Kossa (p ¼ 0.0352) staining
after 4 weeks of culture. The doses are shown in ng/mL concentrations.
The peak effect was seen for the 100-μg/mL dose and dropped off for
higher doses. The bars in the diamond represent mean and 95%
confidence intervals.
Figure 4 Rabbit bone marrow–derived cells were cultured in
monolayer and tested for calcium deposition by Von Kossa staining at
different time points. Von Kossa staining was not observed through
day 21 but appeared at day 28. Both 100 and 250 μg/mL treatments
showed significantly higher mineralization than control on day 28
(p < 0.05).
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reported that long-term (6 months) exposure to nicotine did
not have a detrimental effect on osseointegration of titanium
implants in a rabbit osteotomy model.32
Numerous clinical studies have documented deleterious
effects of smoking on bone healing and spinal fusion.2,33–35
One must be careful, however, to differentiate smoking
exposure from nicotine exposure. Gullihorn et al reported
that although exposure of osteoblast-like cells to nicotine
elicited a dose-dependent increase in metabolic activity,
preparations composed of cigarette smoke condensate with
equivalent levels of nicotine showed reduced alkaline phos-
phatase activity and decreased total protein and collagen
synthesis.36 Skott et al reported the results of exposure to
nicotine, tobacco extract, and both in a rat femur fracture
model.37 When mechanically testing the fracture healing,
they found that ultimate torque and torque at yield point in
rats receiving tobacco extract alone were decreased 21% and
23%, respectively, comparedwith the control (saline infusion)
group and 20% and 26%, respectively, compared with the
nicotine-only group. The combined group (tobacco extract
plus nicotine) demonstrated an 18% torque reduction com-
pared with the nicotine only group, and no difference was
found between the tobacco-only group and the combined
group.37 This suggests that smoking, rather than just nicotine,
may be the prime culprit. Some authors have even hypothe-
sized that low-dose nicotine exposure may be utilized to
reduce the incidence of osteoporosis.38
Conclusions
In conclusion, the results of this study suggest that the
effects of nicotine on osteoblast activity are complex and
dose-dependent and may not always be detrimental. More
research needs to be performed before the effects of nicotine
on healing bone can be determined. Nicotine may not
be responsible for the inhibited bone healing observed in
smokers.
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